A federal judge certifies as class actions a pair of suits claiming Merck & Co. and the former Schering-Plough Corporation withheld information about the effectiveness of the anticholesterol drug Vytorin.
September 27, 2012 at 06:41 PM
1 minute read
A federal judge on Tuesday certified as class actions a pair of suits claiming Merck & Co. and the former Schering-Plough Corporation withheld information about the effectiveness of the anticholesterol drug Vytorin.
Schering, the drug’s maker, comarketed it with Merck through a joint venture prior to the merger of the two companies in November 2009.
Presented by BigVoodoo
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
